Item 4.01. Change in Registrant's Certifying Accountant.
On May 2, 2023, Baker Tilly US, LLP ("Baker Tilly"), the independent registered
public accounting firm to MedAvail Holdings, Inc. (the "Company"), informed the
Audit Committee of the Company's Board of Directors of its decision to resign as
auditors of the Company, effective immediately following the filing of the
Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2023.
The audit report of Baker Tilly on the Company's financial statements for the
year ended December 31, 2022 did not contain an adverse opinion or disclaimer of
opinion and was not qualified or modified as to uncertainty, audit scope, or
accounting principles.
During the year ended December 31, 2022, and the subsequent interim period
through May 8, 2023, there were no: (1) disagreements (as defined in Item
304(a)(1)(iv) of Regulation S-K and the related instructions) with Baker Tilly
on any matter of accounting principles or practices, financial statement
disclosure, or auditing scope or procedure, which disagreements, if not resolved
to the satisfaction of Baker Tilly, would have caused Baker Tilly to make
reference thereto in its report on the financial statements for such year; or
(2) reportable events within the meaning of Item 304(a)(1)(v) of Regulation S-K.
The Company delivered a copy of this Current Report on Form 8-K to Baker Tilly
and requested a letter addressed to the Securities and Exchange Commission
stating whether or not it agrees with the statements made in this Item. Baker
Tilly responded with a letter dated May 8, 2023, a copy of which is filed as
Exhibit 16.1 to this report, stating that Baker Tilly agrees with the statements
set forth in this Item.
Item 9.01 Financial Statement and Exhibits.
(d) Exhibits
Exhibit No. Description
16.1 Letter to the Securities and Exchange Commission from Baker Tilly US, LLP,
dated May 8, 2023
© Edgar Online, source Glimpses
MEDAVAIL HOLDINGS, INC. 
